CGRP 调节疗法：最新进展。

IF 4.8 2区医学 Q1 CLINICAL NEUROLOGY

Current Neurology and Neuroscience Reports Pub Date : 2024-09-01 Epub Date: 2024-07-17 DOI:10.1007/s11910-024-01363-w

Kate Bedrin, Tulsi Shah, Shivani Vaidya, Jessica Ailani

{"title":"CGRP 调节疗法：最新进展。","authors":"Kate Bedrin, Tulsi Shah, Shivani Vaidya, Jessica Ailani","doi":"10.1007/s11910-024-01363-w","DOIUrl":null,"url":null,"abstract":"Introduction: Calcitonin-gene related peptide (CGRP) is a vasoactive neuropeptide involved in the pathophysiology ofmigraine. CGRP has been targeted for both preventive and acute treatment of migraine.Objective: Provide a summary of the most clinically relevant literature surrounding CGRP modulating therapies.Methods: This update on CGRP modulating therapies includes articles selected as most clinically relevant by theauthors.Conclusion: CGRP modulating therapies are an exciting new addition to migraine treatment given their safety andtolerability. Additionally, compared to traditional migraine preventive medication these treatments are migrainespecific.Further real-world and clinical data is ongoing to better understand these treatments that continue to gainfavor in the management of migraine.","PeriodicalId":10831,"journal":{"name":"Current Neurology and Neuroscience Reports","volume":null,"pages":null},"PeriodicalIF":4.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CGRP Modulating Therapies: An Update.\",\"authors\":\"Kate Bedrin, Tulsi Shah, Shivani Vaidya, Jessica Ailani\",\"doi\":\"10.1007/s11910-024-01363-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Calcitonin-gene related peptide (CGRP) is a vasoactive neuropeptide involved in the pathophysiology ofmigraine. CGRP has been targeted for both preventive and acute treatment of migraine.Objective: Provide a summary of the most clinically relevant literature surrounding CGRP modulating therapies.Methods: This update on CGRP modulating therapies includes articles selected as most clinically relevant by theauthors.Conclusion: CGRP modulating therapies are an exciting new addition to migraine treatment given their safety andtolerability. Additionally, compared to traditional migraine preventive medication these treatments are migrainespecific.Further real-world and clinical data is ongoing to better understand these treatments that continue to gainfavor in the management of migraine.\",\"PeriodicalId\":10831,\"journal\":{\"name\":\"Current Neurology and Neuroscience Reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Neurology and Neuroscience Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11910-024-01363-w\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Neurology and Neuroscience Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11910-024-01363-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

导言：降钙素基因相关肽（CGRP）是一种血管活性神经肽，与偏头痛的病理生理学有关。CGRP 已成为偏头痛预防和急性治疗的靶向药物：总结与 CGRP 调节疗法相关的临床文献：方法：这篇关于CGRP调节疗法的更新文章包括作者挑选出的与临床最相关的文章：鉴于其安全性和耐受性，CGRP调节疗法是偏头痛治疗领域令人兴奋的新成员。此外，与传统的偏头痛预防药物相比，这些疗法具有偏头痛特异性。目前正在进一步收集真实世界和临床数据，以更好地了解这些在偏头痛治疗中不断获得青睐的疗法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

CGRP Modulating Therapies: An Update.

Introduction: Calcitonin-gene related peptide (CGRP) is a vasoactive neuropeptide involved in the pathophysiology ofmigraine. CGRP has been targeted for both preventive and acute treatment of migraine.

Objective: Provide a summary of the most clinically relevant literature surrounding CGRP modulating therapies.

Methods: This update on CGRP modulating therapies includes articles selected as most clinically relevant by theauthors.

Conclusion: CGRP modulating therapies are an exciting new addition to migraine treatment given their safety andtolerability. Additionally, compared to traditional migraine preventive medication these treatments are migrainespecific.Further real-world and clinical data is ongoing to better understand these treatments that continue to gainfavor in the management of migraine.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Neurology and Neuroscience Reports 医学-临床神经学

CiteScore

9.20

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Current Neurology and Neuroscience Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of neurological disease and disorders. Presents the views of experts on current advances in neurology and neuroscience Gathers and synthesizes important recent papers on the topic Includes reviews of recently published clinical trials, valuable web sites, and commentaries from well-known figures in the field.